Azilsartan medoxomil

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes

Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea